Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
8 Jan 2016
Transparency notification
Read More
18 Dec 2015
Transparency notification
Read More
18 Dec 2015
Acquisition of own shares
Read More
8 Dec 2015
Transparency notification from BlackRock Inc.
Read More
3 Dec 2015
UCB reinforces its commitment to epilepsy research with a strong presence at the 2015 American Epilepsy Society annual meeting
Read More
25 Nov 2015
Divestiture of Kremers Urban to Lannett completed
Read More
20 Nov 2015
Acquisition of own shares
Read More
20 Nov 2015
UCB receives positive EU CHMP opinion for CIMZIA® (certolizumab pegol) to treat severe, active and progressive rheumatoid arthritis in DMARD-naïve patients
Read More
20 Nov 2015
CHMP recommends EU approval for UCB’s new drug brivaracetam for people with epilepsy
Read More
17 Nov 2015
Transparency notification of The Capital Group Companies, Inc.
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
40
Page
41
Page
42
Page
43
Current page
44
Page
45
Page
46
Page
47
Page
48
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss